On the other hand, the p53R245W mutation activates a transcriptional program enriched for multiple pathways associated with aggressive breast cancer including oxidative phosphorylation, mTOR, cholesterol homeostasis, and epithelial–mesenchymal transition. This evidence concerns the gene MTOR and breast carcinoma.